Intended for healthcare professionals

Letters

Price of interferon beta is similar in UK and Australia

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7338.677/c (Published 16 March 2002) Cite this as: BMJ 2002;324:677
  1. Jacqueline C Napier (jnapier@schering.co.uk), associate medical director
  1. Schering Health Care, Burgess Hill, West Sussex RH15 9NE

    EDITOR—I was moved by Dyson's account of coming to terms with his wife's diagnosis of multiple sclerosis and the difficulties of obtaining access under the NHS to one of the three beta interferon products licensed for this indication.1 Only 2% of people with multiple sclerosis in the United Kingdom are receiving interferon beta, compared with 12-15% elsewhere in Europe and an even higher proportion in the United States. As I work for …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription